Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand… Read more
Sofwave Medical Ltd (SOFW) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.097x
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has a cash flow conversion efficiency ratio of 0.097x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA2.71 Million) by net assets (ILA28.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sofwave Medical Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Sofwave Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sofwave Medical Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sofwave Medical Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BIG Industries Bhd
KLSE:7005
|
-0.091x |
|
ENERGOAPARATURA ZY 02
F:68D
|
N/A |
|
K2 Asset Management Holdings Ltd
AU:KAM
|
0.052x |
|
Afrimat
JSE:AFT
|
0.117x |
|
Restaurant Brands New Zealand Limited
PINK:RTBRF
|
0.098x |
|
TIDEW. MIDS.+INFRASTR.LTD
F:TL5
|
N/A |
|
WINDOW_WINDOW ASIA
BK:WINDOW
|
0.046x |
|
Tissue Repair Ltd
AU:TRP
|
-0.091x |
Annual Cash Flow Conversion Efficiency for Sofwave Medical Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Sofwave Medical Ltd from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA24.53 Million | ILA-2.40 Million | -0.098x | +59.19% |
| 2023-12-31 | ILA26.34 Million | ILA-6.31 Million | -0.239x | +27.61% |
| 2022-12-31 | ILA32.34 Million | ILA-10.69 Million | -0.331x | -636.46% |
| 2021-12-31 | ILA46.70 Million | ILA-2.10 Million | -0.045x | +98.57% |
| 2020-12-31 | ILA1.53 Million | ILA-4.80 Million | -3.133x | -336.15% |
| 2019-12-31 | ILA4.12 Million | ILA-2.96 Million | -0.718x | -- |